UPDATE: Oppenheimer Downgrades PLx Pharma (PLXP) to Perform
Tweet Send to a Friend
(Updated - August 15, 2022 5:17 AM EDT)
Oppenheimer analyst Leland Gershell downgraded PLx Pharma (NASDAQ: PLXP) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Leland Gershell downgraded PLx Pharma (NASDAQ: PLXP) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
